Skip to content
Screener

Omega Healthcare Investors OHI Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

VTR
VentasVTR
$57.04M+0.8%
Welltower logo
WelltowerWELL
$939.18M+170%
National Health Investors logo
National Health InvestorsNHI
$7.46M-10.4%
LTC Properties logo
LTC PropertiesLTC
$73.08M-16.4%
The Ensign Group logo
The Ensign GroupENSG
$3.62M+8.9%
Sabra Healthcare logo
Sabra HealthcareSBRA
$1.88M

Other financials

Income statement

See full
Revenue$328.2M+16.2%
Net income$362.8M+166%
EPS (diluted)$1.19+159%

Balance sheet

See full
Cash & equivalents$39.0M-94.7%
Total debt$29.5M-2.7%
Total equity$5.4B+8.1%
Total assets$10.0B-5.0%

Cash flow

See full
Operating cash flow$217.7M-9.0%
CapEx$17.9M+40.3%
Free cash flow$199.8M-11.8%

Valuation

See full
Market cap$14.68B+23.9%
P/E17.1×-7.8×
P/S11.5×+0.8×

Profitability

See full
Operating margin43.5%
Net margin67%+24.2pp
FCF margin63.6%-6.2pp

Returns & leverage

See full
Return on equity16.5%+5.6pp
Debt / equity0.0×

Where this comes from

Reported directly by Omega Healthcare Investors in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Omega Healthcare Investors’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 11:13 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000888491-26-000024
Line itemJune 30, 2026December 31, 2025
Additional paid-in capital8,807,5598,693,033
Cumulative net earnings5,190,9644,677,092
Cumulative dividends paid(8,696,011)(8,297,416)
Accumulated other comprehensive income58,11079,037
Total stockholders’ equity5,390,5335,181,299
Noncontrolling interest251,760259,200
Total equity5,642,2935,440,499
Total liabilities and equity$10,014,761$10,049,059

Item 1. Financial Statements of Omega Healthcare Investors, Inc. (Unaudited):

FAQ

What is Omega Healthcare Investors's noncontrolling interests in subsidiaries?
Omega Healthcare Investors (OHI) reported noncontrolling interests in subsidiaries of $251.76M in Q2 2026.
How has Omega Healthcare Investors's noncontrolling interests in subsidiaries changed year-over-year?
Omega Healthcare Investors's noncontrolling interests in subsidiaries increased by 25.4% year-over-year, from $200.71M to $251.76M.
What is the long-term trend for Omega Healthcare Investors's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Omega Healthcare Investors's noncontrolling interests in subsidiaries has grown at a 5.9% compound annual growth rate (CAGR), from $194.73M to $259.2M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Omega Healthcare Investors's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude